These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11613533)

  • 1. [A short history of patient package insert in the EU].
    Oshima K
    Yakushigaku Zasshi; 1995; 30(2):164-72. PubMed ID: 11613533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Patient-oriented package inserts for drugs. Historical overview and current status].
    Van Haecht CH; Vander Stichele R; Bogaert M
    Arch Belg; 1989; 47(5-6):230-55. PubMed ID: 2700065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drug information for patients (Package Leaflets), and user testing in EU].
    Yamamoto M; Doi H; Furukawa A
    Yakugaku Zasshi; 2015; 135(2):277-84. PubMed ID: 25747226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A 30-year history of the change in package insert for Japanese pharmaceutical medicines].
    Sasaki K; Kondo T
    Yakushigaku Zasshi; 2004; 39(2):276-85. PubMed ID: 16025649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [History of pharmaceutical packaging in modern Japan. II--Package size of pharmaceuticals].
    Hattori A
    Yakushigaku Zasshi; 2014; 49(2):190-5. PubMed ID: 25799840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The way for carrying medicine and its containers (IX): "Packaging insert in the Edo Period (1600-1867)"].
    Hattori A
    Yakushigaku Zasshi; 1992; 27(2):78-82. PubMed ID: 11639710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The way for carrying medicines and its containers (VI) "Packaging material--glass bottle"].
    Hattori A
    Yakushigaku Zasshi; 1991; 26(2):72-8. PubMed ID: 11623310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale for patient package inserts.
    Morris LA
    Am J Hosp Pharm; 1978 Feb; 35(2):179-84. PubMed ID: 626201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Historical evolution of package inserts in Brazil].
    Caldeira TR; Neves ER; Perini E
    Cad Saude Publica; 2008 Apr; 24(4):737-43. PubMed ID: 18392350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmaceutical information activities].
    Nagayama T
    Yakushigaku Zasshi; 1995; 30(2):71-4. PubMed ID: 11613535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The medicine chest of Roald Amundsen in 1914].
    Gjelsvik AM; Engelskjøn T
    Tidsskr Nor Laegeforen; 1990 Dec; 110(30):3874-7. PubMed ID: 2281451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The medicolegal significance of the package insert.
    Hirsh HL
    Urban Health; 1979 Mar; 8(2):35-7. PubMed ID: 10241525
    [No Abstract]   [Full Text] [Related]  

  • 14. Attitude of physicians toward patient package inserts for medication information in Belgium.
    Stichele RH; De Potter B; Vyncke P; Bogaert MG
    Patient Educ Couns; 1996 Jun; 28(1):5-13. PubMed ID: 8852202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information on marketed drugs for doctors and patients. Experience in six European countries.
    Brown P; Charlish P; Brazier H; Butterfield M
    Int J Technol Assess Health Care; 1995; 11(3):410-6. PubMed ID: 7591543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The way for carrying medicine and its containers (VII): "Packaging art in the Edo Period (1600-1867)"].
    Hattori A
    Yakushigaku Zasshi; 1992; 27(1):50-3. PubMed ID: 11639703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the statements in the information on drug metabolizing enzyme in the package insert--the present regulation and its history in Japan, the U.S. and the U.K.
    Watanabe S; Misu T; Kurihara T; Suzuki S; Sakurada T; Satoh N; Ueda S
    Yakushigaku Zasshi; 2008; 43(2):175-80. PubMed ID: 19579828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Improvement of package insert CYP information for prescription drugs marketed in Japan].
    Hirata-Koizumi M; Saito M; Urano T; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):12-8. PubMed ID: 16541745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excessive medical information increase in package inserts.
    Fuchs J; Werner S; Scheunpflug C; Götze EA; Elstermann K; Scheffel K; Domnowski A; Peter G; Hertzsch C; Hippius M
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):781-90. PubMed ID: 21084033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Compassionate use mechanisms in Europe].
    Sugimura N
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):287-9. PubMed ID: 17301545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.